OncoCyte Corporation (OCX) Income Annual - Discounting Cash Flows
OCX
OncoCyte Corporation
OCX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
Report Filing 2025-05-12 2025-03-24 2024-04-16 2023-04-12 2022-03-11 2021-03-19 2020-04-28 2019-04-01 2018-04-02 2017-02-27 2016-05-24 2014-12-31 2013-12-31
Revenue 3.84 1.88 1.5 0.958 7.73 1.22 0 0 0 0 0 0 0
Cost of Revenue 1.44 1.14 1.09 0.976 7.54 1.85 0.344 0.559 0.58 0.387 0.283 0 0
Gross Profit 2.02 0.74 0.413 -0.018 0.188 -0.639 -0.344 -0.559 -0.58 -0.387 -0.283 0 0
Operating Expenses 60.59 61.78 25.55 17.98 47.13 29.07 21.89 14.64 18.27 10.75 8.44 4.97 3.5
Research & Development 10.11 9.84 9.29 7.3 13.63 9.8 6.79 6.51 7.17 5.68 4.53 3.96 2.94
Selling, General and Administrative 14.59 14.15 13.54 23.01 33.5 23.28 15.45 8.69 11.68 5.46 4.19 1.01 0.552
Other Operating Expenses 35.89 37.79 2.72 -12.34 0 -4.01 -0.344 -0.559 -0.58 -0.387 -0.283 0 0
Operating Income -58.57 -61.04 -25.14 -18 -46.95 -29.71 -22.24 -15.2 -18.85 -11.14 -8.72 -4.97 -3.5
Net Non-Operating Interest -0.04 -0.084 -0.052 -0.083 -0.209 -0.252 0 -0.216 -0.217 -0.028 -0.019 -0.002 0
Interest Income 0 0 0 0 0 0 0.299 0 0 0 0 0 0
Interest Expense 0.04 0.084 0.052 0.083 0.209 0.252 0.299 0.216 0.217 0.028 0.019 0.002 0
Equity & Other Income/(Expense) 0.408 0.462 0.333 -0.532 -26.2 -1.22 -0.187 -0.336 -0.309 0 0.002 -0.011 0
Income Before Tax -58.2 -60.66 -24.86 -18.61 -73.36 -31.19 -22.43 -15.75 -19.38 -11.17 -8.73 -4.99 -3.5
Income Tax Expense 0 0 0 54.83 -9.26 -1.25 -0.097 -0.336 0.217 -0.387 -0.262 -0.009 0
Income Attributable to Non-Controlling Interest 0 0 2.93 0 0 0 0 0.336 -0.217 0.387 0.262 0.009 0
Net Income -58.2 -60.66 -27.78 -73.44 -64.1 -29.93 -22.33 -15.75 -19.38 -11.17 -8.73 -4.99 -3.5
Depreciation and Amortization 1.23 1.56 1.68 5.22 4.21 0.394 0.344 0.559 0.58 0.387 0.283 0.281 0.277
EBITDA -57.34 -59.48 -23.46 -12.78 -42.74 -29.32 -21.89 -14.64 -18.27 -10.75 -8.44 -4.69 -3.22
Earnings Per Share (EPS) -3.53 -4.66 -3.75 -13.26 -14.42 -9.14 -8.71 -8.32 -12.83 -8.42 -8.32 -15.36 -10.77
Diluted Earnings Per Share -3.53 -4.66 -3.75 -13.26 -14.42 -9.14 -8.71 -8.32 -12.83 -8.42 -8.32 -15.36 -10.77
Weighted Average Shares Outstanding 25.69 13.07 7.65 5.54 4.45 3.27 2.56 1.89 1.51 1.33 1.05 0.325 0.325
Diluted Weighted Average Shares Outstanding 25.69 13.07 7.65 5.54 4.45 3.27 2.56 1.89 1.51 1.33 1.05 0.325 0.325
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us